Add to My Stocks
$6.48 $0.37 (6.06%) ALPN stock closing price Sep 18, 2018 (Closing)

The ALPINE IMMUNE cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about ALPINE IMMUNE profits and ALPINE IMMUNE debt. ALPINE IMMUNE saw a cash impact of $37.68M from the issuance of ALPN shares. The cash flow statement helps in the ALPINE IMMUNE stock analysis by providing more information for evaluating changes in assets, liabilities and equities. ALPINE IMMUNE had an outflow of $-16.57M from operating activities, $42.68M inflow due to financing activities, and $-29.8M outflow due to investing activities for 2017.

View details of ALPINE IMMUNE cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow------
Net Increase (Decrease) in Assets Liabilities-3.15M1.79M2.2M-1.07M-0.2M
Cash From (used in) Discontinued Operations------
Other Adjustments Net-5.88M3.26M1.34M-0.22M--0.13M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.58M-0.1M-0.18M--0.12M-0.02M
Acquisition Disposition of Subsidiaires31.13M-----
Increase (Decrease) in Investments-60.34M25.41M-62.26M---
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares37.68M-78.83M29.93M-10.48M
Issuance (Repayment) of Debt Securities5M--8.72M10.81M1.17M
Increase (Decrease) in Bank & Other Borrowings------
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities---2.5M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year11.81M24.99M27.81M1.09M4.7M2.58M
Cash & Equivalents at Year End8.13M24.2M24.99M27.81M1.09M4.7M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Galapagos financial analysis

While ALPINE IMMUNE stock price history provides the price history of a stock, ALPINE IMMUNE stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • ALPINE IMMUNE has cash of $8.13M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the ALPINE IMMUNE stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-16.57M for ALPN.
  • Cash from investing stood at a negative value of $-29.8M for ALPN stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between ALPINE IMMUNE and its owners and creditors and was $42.68M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For ALPINE IMMUNE Cash Flow